Rubric Capital Management LP Trevi Therapeutics, Inc. Transaction History
Rubric Capital Management LP
- $3.38 Billion
- Q2 2024
A detailed history of Rubric Capital Management LP transactions in Trevi Therapeutics, Inc. stock. As of the latest transaction made, Rubric Capital Management LP holds 5,026,931 shares of TRVI stock, worth $14.6 Million. This represents 0.44% of its overall portfolio holdings.
Number of Shares
5,026,931
Previous 5,564,123
9.65%
Holding current value
$14.6 Million
Previous $19.2 Million
21.96%
% of portfolio
0.44%
Previous 0.65%
Shares
4 transactions
Others Institutions Holding TRVI
# of Institutions
76Shares Held
54.4MCall Options Held
15.6KPut Options Held
0-
Nea Management Company, LLC Timonium, MD11.4MShares$33 Million3.2% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA7.38MShares$21.4 Million1.3% of portfolio
-
Viking Global Investors LP4.4MShares$12.8 Million0.05% of portfolio
-
Vr Adviser, LLC New York, NY3.42MShares$9.93 Million1.12% of portfolio
-
Black Rock Inc. New York, NY3.14MShares$9.09 Million0.0% of portfolio
About Trevi Therapeutics, Inc.
- Ticker TRVI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,322,500
- Market Cap $169M
- Description
- Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. The company is developing Haduvio, an oral extended-release formulation of nalbuphine, which is in phase IIb/III clinical trial for the treatment of chronic pruritu...